Advisory Alpha’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$413K Buy
+4,500
New +$394K 0.01% 412
2020
Q4
Sell
-364
Closed -$28K 196
2020
Q3
$28K Buy
+364
New +$27.8K 0.01% 276
2020
Q2
Sell
-371
Closed -$26.4K 170
2020
Q1
$26.4K Buy
+371
New +$26.2K 0.01% 280
2019
Q4
Sell
-34
Closed -$2.4K 785
2019
Q3
$2.4K Buy
+34
New +$2.47K ﹤0.01% 628
2019
Q2
Sell
-35
Closed -$2.48K 203
2019
Q1
$2.48K Buy
+35
New +$2.26K ﹤0.01% 534

Other funds holding CL

Advisory Alpha's CL Position: Q2 2026 in Review

Advisory Alpha opened a new position in Colgate-Palmolive (CL) in Q2 2026: 4,500 shares worth $413K. The stake represents 0.01% of the portfolio and ranks #412 among its holdings. This is a return to the name: Advisory Alpha previously reported a position in CL as recently as Q3 2020.

Advisory Alpha first reported a position in CL in Q1 2019 and has held it in 5 quarters since. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Advisory Alpha held 4,500 shares of Colgate-Palmolive worth $413K as of Q2 2026.
  • Colgate-Palmolive was a new Advisory Alpha position in Q2 2026.
  • Colgate-Palmolive made up 0.01% of Advisory Alpha's portfolio in Q2 2026, its #412 holding.
  • Advisory Alpha first reported a position in Colgate-Palmolive in Q1 2019 and has held it in 5 quarters since.
  • 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Advisory Alpha's 13F filing for Q2 2026, filed 11 Aug 2026.